NLRP3 and Parkinson disease: Importantly, reductions in inflammasome activity via NLRP3 deficiency or inhibition reduce microglial activation and protect against dopaminergic neuronal loss in the SNpc in the MPTP [40] and rotenone mouse models of PD [50].